THE ROLE OF NT PRO-BNP IN THE EVALUATION OF DIABETIC PATIENTS WITH HEART FAILURE.
NT-pro-BNP
diabetes mellitus
heart failure
Journal
Acta endocrinologica (Bucharest, Romania : 2005)
ISSN: 1841-0987
Titre abrégé: Acta Endocrinol (Buchar)
Pays: Romania
ID NLM: 101269720
Informations de publication
Date de publication:
Historique:
entrez:
8
10
2020
pubmed:
9
10
2020
medline:
9
10
2020
Statut:
ppublish
Résumé
The prevalence of patients with concomitant heart failure (HF) and diabetes mellitus (DM) is high. To analyze the role of NT-pro-BNP levels in the evaluation of diabetic patients with heart failure. Retrospective comparative cohort study. A total of 174 patients admitted to our Cardiology Department, previously diagnosed with HF, were enrolled. Among these patients, 47.7% had DM. HF was defined according to the 2016 ESC criteria. The NT-pro BNP levels above 126 pg/mL indicate a high probability of heart failure. In diabetic patients there were significant correlations between NT-pro-BNP values and the following parameters: hemoglobin (rho=-0.28, p=0.01), hematocrit (rho= -0.27, p=0.014), total cholesterol (rho= -0.21, p=0.048), triglycerides (rho= -0.283, p=0.01), ejection fraction (rho= -0.465, p<0.0001), end-diastolic volume (rho= 0.253, p= 0.026), end-systolic volume (rho= 0.29 p=0.01). Only the following 3 parameters: ejection fraction (p= 0.0009), hemoglobin (p= 0.0092) and triglycerides (p= 0.0380) were independent predictive factors for elevated NT-pro-BNP values. In diabetic heart failure patients, the value of NT-pro-BNP holds a pivotal role in the evaluation of their overall status, facilitating the establishment of correct management and follow-up.
Identifiants
pubmed: 33029235
doi: 10.4183/aeb.2020.183
pii: aeb.2020.183
pmc: PMC7535893
doi:
Types de publication
Journal Article
Langues
eng
Pagination
183-191Informations de copyright
©by Acta Endocrinologica Foundation.
Références
Hellenic J Cardiol. 2015 May-Jun;56(3):208-16
pubmed: 26021242
J Diabetes Complications. 2015 Nov-Dec;29(8):1119-23
pubmed: 26387808
Am Heart J. 2005 Feb;149(2):209-16
pubmed: 15846257
J Card Fail. 2012 Mar;18(3):194-201
pubmed: 22385939
J Am Coll Cardiol. 2013 Oct 8;62(15):1365-72
pubmed: 23810874
Am J Cardiol. 2015 Jan 1;115(1):69-74
pubmed: 25456879
Eur Heart J. 2008 May;29(10):1224-40
pubmed: 18424786
Prog Cardiovasc Dis. 2016 Mar-Apr;58(5):537-47
pubmed: 26826295
Can J Cardiol. 2018 May;34(5):624-631
pubmed: 29287943
Curr Cardiol Rep. 2017 Mar;19(3):19
pubmed: 28220465
Diabetes Care. 2004 Mar;27(3):699-703
pubmed: 14988288
Am J Cardiol. 1996 May 1;77(11):1017-20
pubmed: 8644628
Diabetologia. 2006 Oct;49(10):2256-62
pubmed: 16937127
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Diabetes Care. 2010 Jun;33(6):1213-8
pubmed: 20299488
Am J Crit Care. 2017 Mar;26(2):140-148
pubmed: 28249867
Heart Fail Rev. 2013 Mar;18(2):149-66
pubmed: 22453289
Am J Cardiol. 2013 Feb 15;111(4):574-81
pubmed: 23206923
J Am Coll Cardiol. 2004 Sep 1;44(5):1047-52
pubmed: 15337217
J Am Coll Cardiol. 2003 Sep 3;42(5):914-22
pubmed: 12957443
BMC Med. 2017 Jul 3;15(1):123
pubmed: 28669352
Eur Heart J. 2008 Jun;29(11):1377-85
pubmed: 18413309
Eur J Prev Cardiol. 2012 Oct;19(5):944-51
pubmed: 21856715
JAMA. 1979 May 11;241(19):2035-8
pubmed: 430798
Eur J Heart Fail. 2014 Sep;16(9):992-1001
pubmed: 25046483
J Diabetes. 2017 Apr;9(4):320-324
pubmed: 28070960
Int J Cardiol. 2012 May 17;157(1):80-5
pubmed: 21190739
Ann Rheum Dis. 2016 Jan;75(1):91-5
pubmed: 25277955
Herz. 2012 Dec;37(8):880-6
pubmed: 23223771
Exp Ther Med. 2013 Jan;5(1):229-232
pubmed: 23251273
Diabetes Care. 2011 Jul;34(7):1481-6
pubmed: 21593294
Diab Vasc Dis Res. 2013 Jul;10(4):330-6
pubmed: 23349368
J Diabetes. 2016 May;8(3):336-44
pubmed: 25850521
Lancet Diabetes Endocrinol. 2014 Aug;2(8):634-47
pubmed: 24842598
Biochim Biophys Acta. 2009 Jul;1790(7):682-93
pubmed: 18786614
Circulation. 2016 Dec 6;134(23):e535-e578
pubmed: 27799274
Circulation. 2018 Jul 3;138(1):80-98
pubmed: 29967232